Hyderabad: Natco Pharma today reported an over two-fold increase in net profit at Rs 24 crore for the fourth quarter ended March 31, 2014. The city-based company had registered a net profit of Rs 11.32
New Delhi, June 9: India, on Friday, said it had not violated any multi-lateral trade agreement by issuing compulsory licence for patented anti-cancer drug — Nexavar — to be produced and sold at a much
Top News
Latest News
